Investor News Archives - Inify Laboratories

Inify Laboratories AB (publ) – summary of Annual General Meeting

Annual General Meeting, Investor News 2025-05-21

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting on May 20, 2025. A total of 44,461,934 shares were represented at the Annual General Meeting, corresponding […]

Inify Laboratories: Continued strong growth – construction and establishment in the UK

Financial reports, Investor News 2025-04-30

STOCKHOLM – April 30, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continued to deliver sales growth and positive margins in Sweden, alongside steady […]

Inify Laboratories – Annual Report 2024

Annual reports, Financial reports, Investor News 2025-04-16

Stockholm – April 16, 2025 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2024. […]

Inify Laboratories – notice of Annual General Meeting on May 20, 2025

Annual General Meeting, Investor News 2025-04-16

Stockholm – April 16, 2025 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]

Panel talk about Inify’s fourth quarter 2024

Investor News 2025-02-28

Inify Laboratories continues to strengthen its position in the diagnostics market, achieving significant growth and expanding its reach. In Q4 2024, sales increased by 60% compared to the previous quarter […]

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Financial reports, Investor News 2025-02-26

STOCKHOLM – February 26, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, saw sales grow by 60% compared to the previous quarter, and 472% […]

Inify Laboratories – New share capital registered

Investor News 2025-02-14

Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 12 February 2025 regarding the resolution to issue 30,202,366 new shares in a private […]

Inify Laboratories – Resolution to issue new shares in Private Placement and Subsequent Offering

Investor News 2025-02-12

Reference is made to the stock exchange announcements made by Inify Laboratories AB (the "Company") on 16 December 2024 regarding the allocation of 30,202,366 new shares in a private placement […]

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-01-30

Stockholm, Sweden, January 30, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Olof Sandén, board member and […]

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-01-24

Stockholm, Sweden, January 24, 2024; Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 23 January 2024, regarding the final results of […]

Inify Laboratories AB (publ) – summary of Annual General Meeting

Inify Laboratories: Continued strong growth – construction and establishment in the UK

Inify Laboratories – Annual Report 2024

Inify Laboratories – notice of Annual General Meeting on May 20, 2025

Panel talk about Inify’s fourth quarter 2024

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Inify Laboratories – New share capital registered

Inify Laboratories – Resolution to issue new shares in Private Placement and Subsequent Offering

Inify Laboratories – mandatory notification of trade

Inify Laboratories – mandatory notification of trade

Our services

Inify Laboratories

For Investors

Contact us

Social media